Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni DI Zenzo

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Medicine|August 7, 2023
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experienceMartina Merli, Martina Accorinti, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology|October 10, 2025
VARIANT_P: a 14-years multicentric follow-up study of atypical pemphigus variants in ItalyLavinia Quintarelli, Irene Bonanni, Elena Biancamaria Mariotti, et al.
The Journal of Investigative Dermatology|September 17, 2023
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Luca Scarsella, Christoph Hudemann, et al.
Acta Dermato-Venereologica|June 30, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of PatientsAnna Pira, Martina Merli, Feliciana Mariotti, et al.
The Journal of Investigative Dermatology|April 10, 2017
Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016Enno Schmidt, Volker Spindler, Rüdiger Eming, et al.
The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Medicine|August 7, 2023
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experienceMartina Merli, Martina Accorinti, Maurizio Romagnuolo, et al.
Clinical and Experimental Dermatology|October 10, 2025
VARIANT_P: a 14-years multicentric follow-up study of atypical pemphigus variants in ItalyLavinia Quintarelli, Irene Bonanni, Elena Biancamaria Mariotti, et al.
The Journal of Investigative Dermatology|September 17, 2023
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Luca Scarsella, Christoph Hudemann, et al.
Acta Dermato-Venereologica|June 30, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of PatientsAnna Pira, Martina Merli, Feliciana Mariotti, et al.
The Journal of Investigative Dermatology|April 10, 2017
Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016Enno Schmidt, Volker Spindler, Rüdiger Eming, et al.
The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.
Pageof 8